fda import alert green list glp-1 semaglutide tirzepatide 2025 issues 'green list,' raising questions for South Florida FDA's green list cracks down

If semaglutide isn't appropriate, alternatives exist

However, the ongoing research and encouraging clinical trial results provide hope for its eventual availability to patients in the United States

Explore different activities: Pick exercises you like youll stick with them longer

Key Benefits Glossary Significant weight loss: Long-term studies for semaglutide show patients can lose up to 15% of their body weight with proper use

The article treats this window as the reason discontinuation planning matters, and stresses the plan belongs with your prescribing provider rather than being self-directed

Speak with a clinician first